News Center

2025 EHA: Henselbio's KSD-101 DC Vaccine Breakthrough Data Unveiled, Expanding New Boundaries for EBV Hematoma Treatment
June 17, 2025 42
Hengsai BioItaly - Milan The 30th Annual Meeting of the European Hematology Association (EHA 2025) was successfully concluded from June 12 to 15 in Milan, Italy. As a global top event in the field of hematology, EHA gathered the world's top experts, scholars and industrial pioneers to discuss the latest breakthroughs and future direction of blood disease diagnosis and treatment. In this international academic feast, Hengsai Biotechnology, as one of the...
View details
2025 Annual Meeting and Spring Reunion Special Hengsai Biology
April 25, 2025 147
The snake offered a new chapter, and the elites went to the spring banquet together. At the time when the snake is coiled up and everything is new, all the staff of Hengsai Bio-technology gathered together and held the 2025 Annual Meeting and Annual Summarization Activity in Zhoushan, Zhejiang Province. The team of Hengsai traveled on the waves, refined tacit understanding with collaboration, and cohesion of consensus with laughter, and drew the prelude of the New Year together among the blue sea and golden sand. Breaking through ten thousand hectares of waves, the team went on a journey to the blue sea...
View details
Hengsai Bio DC Vaccine for Kidney Cancer Program Officially Launched
March 4, 2025 178
On March 3, 2025, Hengsai Bio's self-developed KSD-201 DC vaccine for advanced renal cell carcinoma was officially launched at Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology ("Wuhan Tongji Hospital").
View details
DC Vaccine for Nasopharyngeal Carcinoma [Medium Swelling] Completes First Patient Enrollment for Dosing
November 12, 2024 357
DC Vaccine for Nasopharyngeal Carcinoma [Medium Swelling] Completes First Patient Enrollment for Dosing
View details
Hengsai Biotechnology Wins the 13th China Innovation and Entrepreneurship Competition (Guangdong Region)
November 4, 2024 279
Hengsai Biotechnology Wins the 13th China Innovation and Entrepreneurship Competition (Guangdong Region)
View details
Hengsai Bio Zhongshan R&D Center Opens
October 28, 2024 376
Hengsai Bio Zhongshan R&D Center Opens
View details
Hengsai Biological Dendritic Cell Vaccine Drug Production and Research Project Groundbreaking Ceremony Successfully Held
August 14, 2024 331
Hengsai Biological Dendritic Cell Vaccine Drug Production and Research Project Groundbreaking Ceremony Successfully Held
View details
Exploring the Mystery of EBV and Tumor 丨Hengsai Biotechnology Shows Its Elegance on the International Academic Stage Again
July 19, 2024 253
Exploring the Mystery of EBV and Tumor 丨Hengsai Biotechnology Shows Its Elegance on the International Academic Stage Again
View details
2024 EHA | Prof. Chunrui Li: Focusing on China's original research power, the field of EBV-associated hematological oncology therapeutics is revitalized
June 21, 2024 187
2024 EHA | Prof. Chunrui Li: Focusing on China's original research power, the field of EBV-associated hematological oncology therapeutics is revitalized
View details
Hengsai Bio 2024 Annual Meeting & Spring Tour Special
April 19, 2024 279
Preface: The dragon is in full bloom, welcome the spring, the elite gathered, the annual event. Looking back to 2023, it is to overcome difficulties and move forward; looking forward to 2024, it is to compete with a hundred boats and oar first. Accompanied by the spring breeze in April, Hengsai Bio held the 2024 annual meeting and spring recreation activities in Anji, Zhejiang Province Spring Sequence Annual feast On April 12, all the staff in a relaxed and happy atmosphere...
View details

Expand more!